These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
313 related articles for article (PubMed ID: 34485329)
1. Swab and Sputum SARS-CoV-2 RNA-Negative, CT-Positive, Symptomatic Contacts of COVID-19 Cases: A Hypothesis-Generating Prospective Population-Based Cohort Study of Eight Clusters. Huang L; Zhang X; Zhang L; Xu J; Wei Z; Xu Y; Zhang C; Xu A Front Med (Lausanne); 2021; 8():685544. PubMed ID: 34485329 [No Abstract] [Full Text] [Related]
2. Reliability of induced sputum test is greater than that of throat swab test for detecting SARS-CoV-2 in patients with COVID-19: A multi-center cross-sectional study. Lai T; Xiang F; Zeng J; Huang Y; Jia L; Chen H; Wu J; Xie J; Liu S; Deng W; Zheng W; Huang Y; Zhang Q; Luo Q; Mo F; Long L; Zhang W; Chen W; Han H Virulence; 2020 Dec; 11(1):1394-1401. PubMed ID: 33073676 [TBL] [Abstract][Full Text] [Related]
3. SARS-CoV-2 seroprevalence and transmission risk factors among high-risk close contacts: a retrospective cohort study. Ng OT; Marimuthu K; Koh V; Pang J; Linn KZ; Sun J; De Wang L; Chia WN; Tiu C; Chan M; Ling LM; Vasoo S; Abdad MY; Chia PY; Lee TH; Lin RJ; Sadarangani SP; Chen MI; Said Z; Kurupatham L; Pung R; Wang LF; Cook AR; Leo YS; Lee VJ Lancet Infect Dis; 2021 Mar; 21(3):333-343. PubMed ID: 33152271 [TBL] [Abstract][Full Text] [Related]
4. Association of Age With Likelihood of Developing Symptoms and Critical Disease Among Close Contacts Exposed to Patients With Confirmed SARS-CoV-2 Infection in Italy. Poletti P; Tirani M; Cereda D; Trentini F; Guzzetta G; Sabatino G; Marziano V; Castrofino A; Grosso F; Del Castillo G; Piccarreta R; Andreassi A; Melegaro A; Gramegna M; Ajelli M; Merler S; JAMA Netw Open; 2021 Mar; 4(3):e211085. PubMed ID: 33688964 [TBL] [Abstract][Full Text] [Related]
5. Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection. Dinnes J; Sharma P; Berhane S; van Wyk SS; Nyaaba N; Domen J; Taylor M; Cunningham J; Davenport C; Dittrich S; Emperador D; Hooft L; Leeflang MM; McInnes MD; Spijker R; Verbakel JY; Takwoingi Y; Taylor-Phillips S; Van den Bruel A; Deeks JJ; Cochrane Database Syst Rev; 2022 Jul; 7(7):CD013705. PubMed ID: 35866452 [TBL] [Abstract][Full Text] [Related]
6. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial. Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543 [TBL] [Abstract][Full Text] [Related]
7. PROTECT Trial: A cluster-randomized study with hydroxychloroquine versus observational support for prevention or early-phase treatment of Coronavirus disease (COVID-19): A structured summary of a study protocol for a randomized controlled trial. Nanni O; Viale P; Vertogen B; Lilli C; Zingaretti C; Donati C; Masini C; Monti M; Serra P; Vespignani R; Grossi V; Biggeri A; Scarpi E; Galardi F; Bertoni L; Colamartini A; Falcini F; Altini M; Massa I; Gaggeri R; Martinelli G Trials; 2020 Jul; 21(1):689. PubMed ID: 32736597 [TBL] [Abstract][Full Text] [Related]
8. Insight into the practical performance of RT-PCR testing for SARS-CoV-2 using serological data: a cohort study. Zhang Z; Bi Q; Fang S; Wei L; Wang X; He J; Wu Y; Liu X; Gao W; Zhang R; Gong W; Su Q; Azman AS; Lessler J; Zou X Lancet Microbe; 2021 Feb; 2(2):e79-e87. PubMed ID: 33495759 [TBL] [Abstract][Full Text] [Related]
9. Rapid asymptomatic transmission of COVID-19 during the incubation period demonstrating strong infectivity in a cluster of youngsters aged 16-23 years outside Wuhan and characteristics of young patients with COVID-19: A prospective contact-tracing study. Huang L; Zhang X; Zhang X; Wei Z; Zhang L; Xu J; Liang P; Xu Y; Zhang C; Xu A J Infect; 2020 Jun; 80(6):e1-e13. PubMed ID: 32283156 [TBL] [Abstract][Full Text] [Related]
10. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial. Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461 [TBL] [Abstract][Full Text] [Related]
11. Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study. Marks M; Millat-Martinez P; Ouchi D; Roberts CH; Alemany A; Corbacho-Monné M; Ubals M; Tobias A; Tebé C; Ballana E; Bassat Q; Baro B; Vall-Mayans M; G-Beiras C; Prat N; Ara J; Clotet B; Mitjà O Lancet Infect Dis; 2021 May; 21(5):629-636. PubMed ID: 33545090 [TBL] [Abstract][Full Text] [Related]
12. Epidemiological and clinical characteristics of coronavirus disease (COVID-19) cases at a screening clinic during the early outbreak period: a single-centre study. Khan M; Khan H; Khan S; Nawaz M J Med Microbiol; 2020 Aug; 69(8):1114-1123. PubMed ID: 32783802 [No Abstract] [Full Text] [Related]
13. Transmission of SARS-CoV-2 by children to contacts in schools and households: a prospective cohort and environmental sampling study in London. Cordery R; Reeves L; Zhou J; Rowan A; Watber P; Rosadas C; Crone M; Storch M; Freemont P; Mosscrop L; Cowley A; Zelent G; Bisset K; Le Blond H; Regmi S; Buckingham C; Junaideen R; Abdulla N; Eliahoo J; Mindlin M; Lamagni T; Barclay W; Taylor GP; Sriskandan S Lancet Microbe; 2022 Nov; 3(11):e814-e823. PubMed ID: 36029775 [TBL] [Abstract][Full Text] [Related]
14. Clinical and imaging findings of discharged patients with SARS-CoV-2 positive anal swab samples: a descriptive study. Zhou H; Zhu L; Leng Y; Wang D; Bai HX; Xiong Z; Shi L; Liao W BMC Infect Dis; 2020 Sep; 20(1):644. PubMed ID: 32873230 [TBL] [Abstract][Full Text] [Related]
15. Daily use of lateral flow devices by contacts of confirmed COVID-19 cases to enable exemption from isolation compared with standard self-isolation to reduce onward transmission of SARS-CoV-2 in England: a randomised, controlled, non-inferiority trial. Love NK; Ready DR; Turner C; Verlander NQ; French CE; Martin AF; Sorensen TB; Metelmann S; Denford S; Rubin GJ; Yardley L; Amlôt R; Hopkins S; Oliver I Lancet Respir Med; 2022 Nov; 10(11):1074-1085. PubMed ID: 36228640 [TBL] [Abstract][Full Text] [Related]
16. Assessment of Day-7 Postexposure Testing of Asymptomatic Contacts of COVID-19 Patients to Evaluate Early Release from Quarantine - Vermont, May-November 2020. Jones A; Fialkowski V; Prinzing L; Trites J; Kelso P; Levine M MMWR Morb Mortal Wkly Rep; 2021 Jan; 70(1):12-13. PubMed ID: 33411700 [TBL] [Abstract][Full Text] [Related]
17. Enhanced contact investigations for nine early travel-related cases of SARS-CoV-2 in the United States. Burke RM; Balter S; Barnes E; Barry V; Bartlett K; Beer KD; Benowitz I; Biggs HM; Bruce H; Bryant-Genevier J; Cates J; Chatham-Stephens K; Chea N; Chiou H; Christiansen D; Chu VT; Clark S; Cody SH; Cohen M; Conners EE; Dasari V; Dawson P; DeSalvo T; Donahue M; Dratch A; Duca L; Duchin J; Dyal JW; Feldstein LR; Fenstersheib M; Fischer M; Fisher R; Foo C; Freeman-Ponder B; Fry AM; Gant J; Gautom R; Ghinai I; Gounder P; Grigg CT; Gunzenhauser J; Hall AJ; Han GS; Haupt T; Holshue M; Hunter J; Ibrahim MB; Jacobs MW; Jarashow MC; Joshi K; Kamali T; Kawakami V; Kim M; Kirking HL; Kita-Yarbro A; Klos R; Kobayashi M; Kocharian A; Lang M; Layden J; Leidman E; Lindquist S; Lindstrom S; Link-Gelles R; Marlow M; Mattison CP; McClung N; McPherson TD; Mello L; Midgley CM; Novosad S; Patel MT; Pettrone K; Pillai SK; Pray IW; Reese HE; Rhodes H; Robinson S; Rolfes M; Routh J; Rubin R; Rudman SL; Russell D; Scott S; Shetty V; Smith-Jeffcoat SE; Soda EA; Spitters C; Stierman B; Sunenshine R; Terashita D; Traub E; Vahey GM; Verani JR; Wallace M; Westercamp M; Wortham J; Xie A; Yousaf A; Zahn M PLoS One; 2020; 15(9):e0238342. PubMed ID: 32877446 [TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy of antiviral combination therapy in symptomatic patients of Covid-19 infection - a randomised controlled trial (SEV-COVID Trial): A structured summary of a study protocol for a randomized controlled trial. Panda PK; Bandyopadhyay A; Singh BC; Moirangthem B; Chikara G; Saha S; Bahurupi YA Trials; 2020 Oct; 21(1):866. PubMed ID: 33081849 [TBL] [Abstract][Full Text] [Related]
19. A Prospective Cohort Study in Nonhospitalized Household Contacts With Severe Acute Respiratory Syndrome Coronavirus 2 Infection: Symptom Profiles and Symptom Change Over Time. Yousaf AR; Duca LM; Chu V; Reses HE; Fajans M; Rabold EM; Laws RL; Gharpure R; Matanock A; Wadhwa A; Pomeroy M; Njuguna H; Fox G; Binder AM; Christiansen A; Freeman B; Gregory C; Tran CH; Owusu D; Ye D; Dietrich E; Pevzner E; Conners EE; Pray I; Rispens J; Vuong J; Christensen K; Banks M; O'Hegarty M; Mills L; Lester S; Thornburg NJ; Lewis N; Dawson P; Marcenac P; Salvatore P; Chancey RJ; Fields V; Buono S; Yin S; Gerber S; Kiphibane T; Dasu T; Bhattacharyya S; Westergaard R; Dunn A; Hall AJ; Fry AM; Tate JE; Kirking HL; Nabity S Clin Infect Dis; 2021 Oct; 73(7):e1841-e1849. PubMed ID: 32719874 [TBL] [Abstract][Full Text] [Related]
20. Household secondary attack rate of COVID-19 and associated determinants in Guangzhou, China: a retrospective cohort study. Jing QL; Liu MJ; Zhang ZB; Fang LQ; Yuan J; Zhang AR; Dean NE; Luo L; Ma MM; Longini I; Kenah E; Lu Y; Ma Y; Jalali N; Yang ZC; Yang Y Lancet Infect Dis; 2020 Oct; 20(10):1141-1150. PubMed ID: 32562601 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]